A theme like lives matter is here all sorts of groups from different parts of the community are protesting the drivers obviously around d. C. Are pretty angry but as the presses point out there is a Climate Emergency under way so you might have to have a bit of a slow commutes at least today lets turn to other news now and at least 40 people have been killed in afghanistan in whats believed to have been an air strike that happens in the muscle collar region of Helmand Province people have gone that arent sign to locals facility wounded are being treated authorities are investigating reports that the airstrike hit a wedding celebration a mistake correspondent robin wright has more from kabul. This seems to have been a Major Military operation in the mussa color district of Helmand Province this is a known taliban stronghold involving both it seems Ground Forces and also an airstrike now the ministry of defense here in kabul is talking about this in terms of being a successful military o
South koreas Prime Minister says the deadly mers outbreak is coming to an end and has urged people to go back to their normal lives. And entertainment firms from around the world are looking to take their roller coasters and Service Experiences to china. Prime minister shinzo abe has stressed the need to change the nations security policy. He says the proposed legislation would demonstrate the strength of the japan u. S. Alliance as china increases its maritime presence. The set of bills would expand the role of the selfdefense forces and allow the country to exercise its rights of collective self defense. Abe says leaders in beijing have been carrying out largescale reclamation work in the south china sea. He says theyre not abiding by the 2008 agreement with japan to jointly develop gas fields in parts of the east china sea. He also says Chinese Government vessels have repeatedly entered japans territorial waters around the senkaku islands. Japan controls the islands. China and taiwa
Aat better way to launch with 4 billion deal in the generic drugs industry. John is here with the details. We are talking about ranbaxy. Thats right. Clearly, shares were rising in that region, but sun pharma agreed to by ranbaxy at 4. 1 billion. Here,sting, the movement the Japanese Company owning a large part of ranbaxy. It is a done deal essentially . Yes. In 2008, the Company Bought ranbaxy for for for 1 billion. With u. S. Ssues authorities. It has been a problem child. Ranbaxy, for plans that didnt pass muster with the u. S. Authorities. The fda, the food and Drug Administration in the states, ranbaxy had to recall some batches of its generic cholesterollowering drugs. That is a concern clearly. It is not good for the image. , and indian company, is agreeing to by ranbaxy. Ranbaxy shares soared last week 26 . Encouraging for earnings. It will become the fifth biggest speciality generic drug company in the world. They must deal with this u. S. Issue. That is a concern. Japans thir
We will be tracking those across asia. We see shares in jakarta contained continuing again and a similar story in vietnam today. The Malaysian Ringgit climbing today. Rebels in india are making some rebels in libya are making some surprising moves. As elections kickoff and india, what better way than to launch all this off with a big deal as well. A 4 billion deal as far as generic Drugs Industry goes. It was a headache for one investor group. So we have another company who is prepared to take on that headache. The discount taking place perhaps because of it. Last week, ranbaxy rose 26 . Today, the ag sankyo which bought it back in 2008 is one of the for one of the few gainers on the naked 225, up 4. 5 . So that is clearly a market thumbsup on this deal. They are selling a 4 billion allstop bill. Allstock deal. They did not meet standards of the faa of the fda. There is an fda cloud hanging over it. Daiichi also has the fda hanging over one of its units. Ranbaxy already knows about the
Findings from ASCO 2024 suggest deruxtecan (T-DXd) may become a preferred first-line treatment for patients with hormone receptor (HR)-positive, HER2-low metastatic breast cancer that progressed after endocrine therapy.